Prognostic Stage III Breast Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for Paclitaxel (DB01229)

Also known as: Prognostic Stage 3 Breast Cancer AJCC v8

IndicationStatusPhase
DBCOND0109635 (Prognostic Stage III Breast Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04216472Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN AlterationsTreatment
NCT04001829Docetaxel or Paclitaxel in Reducing Chemotherapy-Induced Peripheral Neuropathy in African American Patients With Stage I-III Breast CancerSupportive Care